title: VEGF and VEGFR2 in dentigerous cysts associated with impacted third molars.
abstract: The aims of this study were to determine the presence and distribution of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor-2 (VEGFR2) in dentigerous cysts compared with normal dental follicles as a control tissue and to evaluate endothelial cells and proliferating cells as indicators of angiogenic activity in these tissues.Twenty specimens histologically diagnosed as dentigerous cysts and 20 dental follicle specimens were included. Immunohistochemistry (IHC) using anti-VEGF and anti-VEGFR2 antibodies stained for the growth factor and its receptor, while anti-CD34 and anti-CD146 antibodies were used to identify endothelial cells. Anti-proliferating cell nuclear antigen (PCNA) antibody detected proliferating cells within the specimens. Slides were examined microscopically and results evaluated using kappa statistics, negative binomial regression and ordinal logistic regression.The mean age for patients with dentigerous cysts was 23 years and they were more common in males. Proteins for VEGF, VEGFR2, PCNA, CD34, and CD146 were expressed in all dentigerous cysts and dental follicles. VEGF and VEGFR2 were expressed on several cell types within the tissues, however there was a significantly greater percentage of positive staining in dentigerous cysts compared with dental follicles (odds ratio = 31.24, p < 0.001). CD34(+), CD146(+), and PCNA(+) cells were observed in both dentigerous cysts and dental follicles but for all markers there were significantly more positive cells in dentigerous cysts (p < 0.001); this was especially evident in cases associated with inflammation. PCNA was seen in most endothelial cells lining small thin walled blood vessels suggesting endothelial proliferation. There was a high level of intra- and inter-examiner agreement (kappa 0.77 and 0.75, respectively).VEGF and VEGFR2 and angiogenic activity are present in dental follicles and dentigerous cysts and may contribute to local bone resorption for tooth eruption or the development and progression of dentigerous cysts.
authors.affiliation: 1Sir John Walsh Research Institute, Faculty of Dentistry, University of Otago 2Department of Preventive and Social Medicine, Faculty of Medicine, University of Otago, Dunedin, New Zealand.
authors.forename: L T
authors.initials: LT
authors.lastname: Friedlander
authors.forename: H
authors.initials: H
authors.lastname: Hussani
authors.forename: M P
authors.initials: MP
authors.lastname: Cullinan
authors.forename: G J
authors.initials: GJ
authors.lastname: Seymour
authors.forename: R K
authors.initials: RK
authors.lastname: De Silva
authors.forename: H
authors.initials: H
authors.lastname: De Silva
authors.forename: C
authors.initials: C
authors.lastname: Cameron
authors.forename: A M
authors.initials: AM
authors.lastname: Rich
mesh_terms: D000293:Adolescent; D000328:Adult; D049109:Cell Proliferation / Q000502:physiology; D003803:Dentigerous Cyst / Q000378:metabolism* / Q000473:pathology; D042783:Endothelial Cells / Q000378:metabolism*; D005260:Female; D006801:Humans; D007150:Immunohistochemistry / Q000379:methods; D007249:Inflammation / Q000473:pathology; D008297:Male; D008964:Molar, Third / Q000378:metabolism*; D009389:Neovascularization, Pathologic / Q000473:pathology; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism*; D040301:Vascular Endothelial Growth Factor Receptor-2 / Q000378:metabolism*; D055815:Young Adult
chemical_list: C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; C000588866:KDR protein, human; D040301:Vascular Endothelial Growth Factor Receptor-2